1. Home
  2. OSPN vs ZURA Comparison

OSPN vs ZURA Comparison

Compare OSPN & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$10.93

Market Cap

390.0M

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.72

Market Cap

521.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
ZURA
Founded
1991
2022
Country
United States
United States
Employees
N/A
30
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.0M
521.8M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
OSPN
ZURA
Price
$10.93
$5.72
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$16.67
$13.00
AVG Volume (30 Days)
532.8K
593.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
4.75%
N/A
EPS Growth
28.77
N/A
EPS
1.88
N/A
Revenue
$243,180,000.00
N/A
Revenue This Year
$3.22
N/A
Revenue Next Year
$3.16
N/A
P/E Ratio
$5.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.07
$0.99
52 Week High
$18.13
$7.25

Technical Indicators

Market Signals
Indicator
OSPN
ZURA
Relative Strength Index (RSI) 53.09 45.02
Support Level $10.20 $5.35
Resistance Level $10.98 $5.75
Average True Range (ATR) 0.38 0.39
MACD 0.06 -0.01
Stochastic Oscillator 64.02 40.57

Price Performance

Historical Comparison
OSPN
ZURA

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: